EDGAR Filing Documents for 0001144204-12-066135

Form F-1 - Registration statement for certain foreign private issuers:

SEC Accession No. 0001144204-12-066135

Filing Date

2012-12-03

Accepted

2012-12-03 17:25:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-1	v329432_f1.htm	F-1	1845278
2	EXHIBIT 4.37	v329432_ex4-37.htm	EX-4.37	214081
3	EXHIBIT 4.38	v329432_ex4-38.htm	EX-4.38	175450
4	EXHIBIT 4.39	v329432_ex4-39.htm	EX-4.39	116265
5	GRAPHIC	tlogo.jpg	GRAPHIC	14866
6	EXHIBIT 5.1	v329432_ex5-1.htm	EX-5.1	48016
7	EXHIBIT 23.1	v329432_ex23-1.htm	EX-23.1	4377
	Complete submission text file	0001144204-12-066135.txt		2425053

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-185247 | Film No.: 121238424
SIC: 2834 Pharmaceutical Preparations